Overall, together with unaltered inhibitory SMADs and PAI-1 mRNA expression in SuHx rats, these observations indicate the involvement of different regulation mechanisms and different target genes of TGF-β-SMAD2/3 signaling in the two PAH animal models. The gene discussed is TGFB1; the disease is pulmonary arterial hypertension.